{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:26:10Z","timestamp":1790623570271,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.pbb.2020.172913","type":"journal-article","created":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T21:02:58Z","timestamp":1584651778000},"page":"172913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Cortical and raphe GABAA, AMPA receptors and glial GLT-1 glutamate transporter contribute to the sustained antidepressant activity of ketamine"],"prefix":"10.1016","volume":"192","author":[{"given":"Thu Ha","family":"Pham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Defaix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Mai Loan","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indira","family":"Mendez-David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Tritschler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis J.","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain M.","family":"Gardier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pbb.2020.172913_bb0010","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.4088\/JCP.16l11277","article-title":"The antidepressant effect of repeat dose intravenous ketamine is delayed by concurrent benzodiazepine use","volume":"78","author":"Albott","year":"2017","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2020.172913_bb0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1523\/JNEUROSCI.3114-15.2016","article-title":"Previous ketamine produces an enduring blockade of neurochemical and behavioral effects of uncontrollable stress","volume":"36","author":"Amat","year":"2016","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.pbb.2020.172913_bb0020","doi-asserted-by":"crossref","first-page":"e858","DOI":"10.4088\/JCP.17f11802","article-title":"Ketamine for depression, 5: potential pharmacokinetic and Pharmacodynamic drug interactions","volume":"78","author":"Andrade","year":"2017","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.pbb.2020.172913_bb0025","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.pbb.2020.172913_bb0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jneumeth.2004.04.042","article-title":"Rapid and precise method to locate microdialysis probe implantation in the rodent brain","volume":"140","author":"Bert","year":"2004","journal-title":"J. Neurosci. Methods"},{"issue":"2","key":"10.1016\/j.pbb.2020.172913_bb0035","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/2045125313507739","article-title":"Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy","volume":"4","author":"Caddy","year":"2014","journal-title":"Ther Adv Psychopharmacol"},{"issue":"6","key":"10.1016\/j.pbb.2020.172913_bb0040","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/j.1471-4159.2010.06880.x","article-title":"Strain-dependent serotonin neuron feedback control: role of serotonin 2C receptors","volume":"114","author":"Calcagno","year":"2010","journal-title":"J. Neurochem."},{"issue":"9","key":"10.1016\/j.pbb.2020.172913_bb0045","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/mp.2015.176","article-title":"Activation of a ventral hippocampus-medial prefrontal cortex pathway is both necessary and sufficient for an antidepressant response to ketamine","volume":"21","author":"Carreno","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"10.1016\/j.pbb.2020.172913_bb0050","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pbb.2020.172913_bb0055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jpba.2018.01.039","article-title":"Rapid analysis of glutamate, glutamine and GABA in mice frontal cortex microdialysis samples using HPLC coupled to electrospray tandem mass spectrometry","volume":"152","author":"Defaix","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"7","key":"10.1016\/j.pbb.2020.172913_bb0065","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/sj.npp.1300433","article-title":"Effects of chronic fluoxetine in animal models of anxiety and depression","volume":"29","author":"Dulawa","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pbb.2020.172913_bb0070","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nm.4050","article-title":"Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants","volume":"22","author":"Duman","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.pbb.2020.172913_bb0075","article-title":"Role of BDNF in the pathophysiology and treatment of depression: activity-dependent effects distinguish rapid-acting antidepressants","author":"Duman","year":"2019","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pbb.2020.172913_bb0080","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neuroscience.2016.02.056","article-title":"Recovery from ketamine-induced amnesia by blockade of GABA-A receptor in the medial prefrontal cortex of mice","volume":"344","author":"Farahmandfart","year":"2017","journal-title":"Neuroscience"},{"issue":"18","key":"10.1016\/j.pbb.2020.172913_bb0085","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1007\/s00213-014-3664-5","article-title":"Ketamine administration in depressive disorders: a systematic review and meta-analysis","volume":"231","author":"Fond","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2020.172913_bb0090","first-page":"225","article-title":"Efficacy and safenty of low-dose intravenous ketamine hydrochloride and concurrent intravenous diazepal in the inductiion and maintenance of balanced anesthesia","volume":"31","author":"Fontenot","year":"1982","journal-title":"Clin Pharm Ther"},{"issue":"3","key":"10.1016\/j.pbb.2020.172913_bb0095","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/JCP.0000000000000316","article-title":"Concomitant benzodiazepine use attenuates ketamine response: implications for large scale study design and clinical development","volume":"35","author":"Frye","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"issue":"26","key":"10.1016\/j.pbb.2020.172913_bb0100","doi-asserted-by":"crossref","first-page":"8106","DOI":"10.1073\/pnas.1414728112","article-title":"Optogenetic stimulation of infralimbic PFC reproduces ketamine\u2019s rapid and sustained antidepressant actions","volume":"112","author":"Fuchikami","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.pbb.2020.172913_bb0105","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/npp.2015.233","article-title":"The antidepressant effects of an mGlu2\/3 receptor antagonist and ketamine require AMPA receptor stimulation in the mPFC and subsequent activation of the 5-HT neurons in the DRN","volume":"41","author":"Fukumoto","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.pbb.2020.172913_bb0110","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1111\/j.1460-9568.2007.05577.x","article-title":"AMPA and NMDA receptor regulation of firing activity in 5-HT neurons of the dorsal and median raphe nuclei","volume":"25","author":"Gartside","year":"2007","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.pbb.2020.172913_bb0115","doi-asserted-by":"crossref","first-page":"e1038","DOI":"10.1038\/tp.2017.7","article-title":"Glial GLT-1 blockade in infralimbic cortex as a new strategy to evoke rapid antidepressant-like effects in rats","volume":"7","author":"Gasull-Camos","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pbb.2020.172913_bb0120","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neuropharm.2018.06.029","article-title":"Serotonergic mechanisms involved in antidepressant-like responses evoked by GLT-1 blockade in rat infralimbic cortex","volume":"139","author":"Gasull-Camos","year":"2018","journal-title":"Neuropharmacology"},{"issue":"2\u20133","key":"10.1016\/j.pbb.2020.172913_bb0125","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0197-0186(00)00019-X","article-title":"The high-affinity glutamate transporters GLT1, GLAST, and EAAT4 are regulated via different signalling mechanisms","volume":"37","author":"Gegelashvili","year":"2000","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.pbb.2020.172913_bb0130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0306-4522(98)00157-2","article-title":"An electrophysiological and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat","volume":"87","author":"Hajos","year":"1998","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.pbb.2020.172913_bb0135","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0197-0186(98)00081-3","article-title":"Mechanism by which GABA, through its GABA(A) receptor, modulates glutamate release from rat cortical neurons in culture","volume":"34","author":"Herrero","year":"1999","journal-title":"Neurochem. Int."},{"issue":"2","key":"10.1016\/j.pbb.2020.172913_bb0140","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/sj.npp.1301399","article-title":"Behavioral effects of chronic fluoxetine in BALB\/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor","volume":"33","author":"Holick","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.pbb.2020.172913_bb0145","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbr.2012.08.016","article-title":"Acute and sustained effects of a metabotropic glutamate 5 receptor antagonist in the novelty-suppressed feeding test","volume":"235","author":"Iijima","year":"2012","journal-title":"Behav Brain"},{"issue":"5","key":"10.1016\/j.pbb.2020.172913_bb0150","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/BF03012584","article-title":"Inhibition by diazepam of ketamine-induced hyperlocomotion and dopamine turnover in mice","volume":"45","author":"Irifune","year":"1998","journal-title":"Can. J. Anaesth."},{"issue":"1","key":"10.1016\/j.pbb.2020.172913_bb0155","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1213\/00000539-200007000-00043","article-title":"Evidence for GABA(A) receptor agonistic properties of ketamine: convulsive and anesthetic behavioral models in mice","volume":"91","author":"Irifune","year":"2000","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.pbb.2020.172913_bb0160","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neuroscience.2010.12.012","article-title":"Mechanisms underlying ketamine-induced synaptic depression in rat hippocampus-medial prefrontal cortex pathway","volume":"177","author":"Kamiyama","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2020.172913_bb0165","series-title":"Requirement of AMPA Receptor Stimulation for the Sustained Antidepressant Activity of Ketamine and LY341495 during the Forced Swim Test in Rats","author":"Koike","year":"2014"},{"issue":"1","key":"10.1016\/j.pbb.2020.172913_bb0170","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbr.2011.05.035","article-title":"Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression","volume":"224","author":"Koike","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2020.172913_bb0175","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pbb.2013.03.017","article-title":"Effects of ketamine and LY341495 on the depressive-like behavior of repeated corticosterone-injected rats","volume":"107","author":"Koike","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"5994","key":"10.1016\/j.pbb.2020.172913_bb0180","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.pbb.2020.172913_bb0185","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.biopsych.2010.12.015","article-title":"Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure","volume":"69","author":"Li","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.pbb.2020.172913_bb0190","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.biopsych.2011.09.030","article-title":"Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex","volume":"71","author":"Liu","year":"2012","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.pbb.2020.172913_bb0195","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00213-015-4128-2","article-title":"Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression","volume":"233","author":"Liu","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2020.172913_bb0200","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pnpbp.2018.07.022","article-title":"Ketamine promotes rapid and transient activation of AMPA receptor-mediated synaptic transmission in the dorsal raphe nucleus","volume":"88","author":"Llamosas","year":"2019","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.pbb.2020.172913_bb0205","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/sj.npp.1301356","article-title":"Clozapine and haloperidol differently suppress the MK-801-increased glutamatergic and serotonergic transmission in the medial prefrontal cortex of the rat","volume":"32","author":"Lopez-Gil","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.pbb.2020.172913_bb0210","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1017\/S1461145711001064","article-title":"Importance of inter-hemispheric prefrontal connection in the effects of non-competitive NMDA receptor antagonists","volume":"15","author":"Lopez-Gil","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.pbb.2020.172913_bb0220","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","article-title":"Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors","volume":"63","author":"Maeng","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2020.172913_bb0225","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neuropharm.2015.07.028","article-title":"Two cellular hypotheses explaining the initiation of ketamine\u2019s antidepressant actions: direct inhibition and disinhibition","volume":"100","author":"Miller","year":"2016","journal-title":"Neuropharmacology"},{"issue":"2\u20133","key":"10.1016\/j.pbb.2020.172913_bb0230","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0014-2999(00)00263-6","article-title":"Modulation of [3H]MK-801 binding to NMDA receptors in vivo and in vitro","volume":"397","author":"Murray","year":"2000","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.pbb.2020.172913_bb0235","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1176\/appi.ajp.2015.15040465","article-title":"Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression","volume":"172","author":"Newport","year":"2015","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2020.172913_bb0240","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1476-5381.2012.01850.x","article-title":"Blockade of the high-affinity noradrenaline transporter (NET) by the selective 5-HT reuptake inhibitor escitalopram: an in vivo microdialysis study in mice","volume":"168","author":"Nguyen","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.pbb.2020.172913_bb0245","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1017\/S1461145714000649","article-title":"Raphe AMPA receptors and nicotinic acetylcholine receptors mediate ketamine-induced serotonin release in the rat prefrontal cortex","volume":"17","author":"Nishitani","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2020.172913_bb0250","article-title":"Antidepressants plus benzodiazepines for adults with major depression","volume":"6","author":"Ogawa","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5037","key":"10.1016\/j.pbb.2020.172913_bb0255","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1126\/science.1835799","article-title":"NMDA antagonist neurotoxicity: mechanism and prevention","volume":"254","author":"Olney","year":"1991","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.pbb.2020.172913_bb0260","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0306-4522(97)00268-6","article-title":"Forebrain afferents to the rat dorsal raphe nucleus demonstrated by retrograde and anterograde tracing methods","volume":"82","author":"Peyron","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2020.172913_bb0265","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pharmthera.2019.02.017","article-title":"Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies: a review","volume":"199","author":"Pham","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pbb.2020.172913_bb0275","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neuropharm.2016.05.010","article-title":"Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB\/cJ mice","volume":"112","author":"Pham","year":"2017","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2020.172913_bb0270","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.biopsych.2017.10.020","article-title":"Common neurotransmission recruited in (R,S)-ketamine and (2R,6R)-hydroxynorketamine-induced sustained antidepressant-like effects","volume":"84","author":"Pham","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2020.172913_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cercor\/bhh104","article-title":"Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: involvement of serotonin and GABA","volume":"15","author":"Puig","year":"2005","journal-title":"Cereb. Cortex"},{"issue":"6","key":"10.1016\/j.pbb.2020.172913_bb2005","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.biopsych.2016.02.009","article-title":"Bidirectional Homeostatic Regulation of a Depression-Related Brain State by Gamma-Aminobutyric Acidergic Deficits and Ketamine Treatment","volume":"80","author":"Ren","year":"2016","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.pbb.2020.172913_bb0285","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.pharep.2016.05.010","article-title":"Antidepressant-like effects of ascorbic acid and ketamine involve modulation of GABAA and GABAB receptors","volume":"68","author":"Rosa","year":"2016","journal-title":"Pharmacol. Rep."},{"issue":"11","key":"10.1016\/j.pbb.2020.172913_bb0290","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.pbb.2020.172913_bb2000","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archpsyc.61.7.705","article-title":"Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression","volume":"61","author":"Sanacora","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2020.172913_bb0295","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/1073858411435129","article-title":"Diversity in NMDA receptor composition: many regulators, many consequences","volume":"19","author":"Sanz-Clemente","year":"2013","journal-title":"Neuroscientist"},{"issue":"12","key":"10.1016\/j.pbb.2020.172913_bb0300","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1523\/JNEUROSCI.3195-17.2018","volume":"38","author":"Sellmeijer","year":"2018","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.pbb.2020.172913_bb0305","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1177\/0269881110368873","article-title":"Transient inactivation of the infralimbic cortex induces antidepressant-like effects in the rat","volume":"25","author":"Slattery","year":"2011","journal-title":"J. Psychopharmacol."},{"issue":"6 Suppl","key":"10.1016\/j.pbb.2020.172913_bb0310","first-page":"S28","article-title":"Depression and anxiety","volume":"199","author":"Tiller","year":"2013","journal-title":"Med. J. Aust."},{"issue":"1","key":"10.1016\/j.pbb.2020.172913_bb0315","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/syn.10279","article-title":"Differential projections of the infralimbic and prelimbic cortex in the rat","volume":"51","author":"Vertes","year":"2004","journal-title":"Synapse"},{"issue":"4","key":"10.1016\/j.pbb.2020.172913_bb0320","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv124","article-title":"Effects of low-dose and very low-dose ketamine among patients with major depression: a systematic review and meta-analysis","volume":"19","author":"Xu","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2020.172913_bb0325","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1038\/tp.2013.112","article-title":"A possible mechanism of the nucleus accumbens and ventral pallidum 5-HT1B receptors underlying the antidepressant action of ketamine: a PET study with macaques","volume":"4","author":"Yamanaka","year":"2014","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2020.172913_bb0330","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1124\/jpet.115.225664","article-title":"The Prodrug 4-Chlorokynurenine causes ketamine-like antidepressant effects, but not side effects, by NMDA\/GlycineB-site inhibition","volume":"355","author":"Zanos","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2020.172913_bb0335","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.pbb.2020.172913_bb0340","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305719306483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305719306483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:37:39Z","timestamp":1758775059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305719306483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":67,"alternative-id":["S0091305719306483"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2020.172913","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.03.04.976308","asserted-by":"object"}]},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cortical and raphe GABAA, AMPA receptors and glial GLT-1 glutamate transporter contribute to the sustained antidepressant activity of ketamine","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2020.172913","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"172913"}}